Tuberculosis is an airborne disease that causes more deaths than any other infectious disease, infecting about 2 billion people worldwide and 15 million in the United States. TB is caused by the bacterium Mycobacterium tuberculosis, which spreads when a person with TB of the lungs or throat coughs, sneezes, sings or talks. The bacterium can float in the air for several hours and can infect anyone who breathes in the contamination. TB is not spread by shaking someone’s hand, sharing food or drink, touching bed linens or toilet seats, sharing toothbrushes or kissing.
The bacterium usually attacks the lungs but can also damage other parts of the body such as the brain, kidneys or spine. Symptoms of TB in the lungs include a bad cough that lasts three weeks or longer, weight loss, loss of appetite, coughing up blood or mucus, weakness or fatigue, fever and night sweats. If you have these symptoms, contact your health care provider or local health department.
If you have been exposed, your health care provider can order skin tests, blood tests, X-rays and other tests to determine if you have TB. In most cases, TB is treatable and curable by taking several medicines for a long time. If not treated properly, TB can be deadly.
Multidrug-resistant tuberculosis, or MDR-TB, is tuberculosis that does not respond to Isoniazid and Rifampin, the two most powerful, first-line, anti-TB drugs. According to the World Health Organization, MDR-TB is a major worldwide public health problem, threatening the progress made in TB care and control.
The primary cause of drug resistance is mismanagement of treatment. Most people with tuberculosis are cured by a strictly followed, six-month drug regimen administered with support and supervision. Inappropriate or incorrect use of medications or use of ineffective formulations of drugs, as well as prematurely stopping treatment, can cause drug resistance. As the bacterium develops the ability to withstand antibiotic attack, it relays that ability to its offspring and the drug-resistant disease is transmitted to others.
In some countries where treatment options are limited or expensive, it is increasingly difficult to treat MDR-TB. Recommended medicines may not be available; and without proper monitoring, patients who experience adverse effects from the drugs may discontinue use. The best ways to control MDR-TB are to cure the patient the first time around, provide adequate infection prevention in treatment facilities and monitor the use of recommended second-line drugs.
In some cases, more severe drug resistance develops. Extensively drug-resistant tuberculosis, or XDR-TB, responds to even fewer available medicines and has been reported in 92 countries. XDR-TB is resistant to Isoniazid, Rifampin, fluoroquinolone broad-spectrum antibiotics and at least one of the three injectable second-line drugs (Amikacin, Kanamycin and Capreomycin), leaving patients with less effective treatment options.
In 2012, an estimated 450,000 people developed drug-resistant TB worldwide; about 9.6 percent had XDR-TB. Persons with HIV infection or otherwise weakened immune systems are particularly susceptible to XDR-TB; they are more likely to develop TB once they are exposed and also have a higher risk of death from TB.
If you are diagnosed with TB, the best way to prevent the spread of MDR-TB is to take all your medications exactly as prescribed. Do not miss any doses or stop treatment early. Patients should tell their health care provider if they have trouble taking the medications. Patients who plan to travel should talk to their health care provider and pack enough medicine for the duration of the trip.
Health care providers can help prevent MDR-TB by quickly diagnosing cases, following recommended treatment guidelines, monitoring patients’ response to treatment and making sure therapy is completed. It is also important to avoid exposure to known MDR-TB patients in closed or crowded places such as hospitals, prisons or homeless shelters.
U.S. cases of MDR-TB decreased since 1993, when the Centers for Disease Control expanded the TB surveillance system to include drug susceptibility results. Since 1997, the percentage of U.S.-born patients with MDR-TB remained below 1 percent. However, the proportion of total reported primary MDR-TB cases occurring in foreign-born persons increased from 25.3 percent in 1993 to 86.1 percent in 2012.
Although MDR-TB and XDR-TB occur globally, they are still rare. HIV-infected travelers are at the greatest risk if they come in contact with a person with MDR-TB or XDR-TB, but all travelers should avoid high-risk settings where no infection control measures are in place.
Air travel carries a relatively low risk for TB infection. There has to be someone with infectious TB on the same flight to present any danger; the risk also depends on the extent of the disease in that person, ventilation and duration of exposure (risk is higher on flights lasting eight hours or longer).
Travelers should avoid close contact or prolonged time with known TB patients in crowded, enclosed environments. Anyone who will be working in clinics, hospitals or other health care settings where TB patients are likely to be encountered should consult infection prevention or occupational health experts. Ask about administrative and environmental procedures for preventing exposure. Once those procedures are implemented, use additional measures such as personal respiratory protective devices.
The content of this article is for informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition.
Read This Next
Lotte Hotel Seoul
2014 / February 2014Jun 1, 2016
All Reads on This Topic
Read Them All
FX Excursions offers the chance for once-in-a-lifetime experiences in destinations around the world.
Diego Rivera’s America Presents the Most In-Depth Look at Artist’s Work in More than 20 Years
Crystal Bridges Museum of American Art, located in Bentonville, Arkansas, presents Diego Rivera’s America, the first major exhibition focused solely on the Mexican artist in more than 20 years, on view until July 31. Crystal Bridges is the second and final stop for the exhibition, the only remaining opportunity for visitors to experience Rivera's expansive vision of America.
Share Your Travel Preferences with Global Traveler in a Short Survey & Win
Learning more about our readers’ travel habits and preferences ensures Global Traveler delivers the content you desire. As the travel industry has adapted and changed over the last few years, it’s more important than ever to connect. To best meet your short- and long-term travel content needs, please help us!
San Antonio, Texas, Preserves Architectural Beauty for Future Generations
In San Antonio, Texas, old buildings are seldom destroyed. When they fall into disrepair, they are instead repurposed and restored to maintain the city’s history and traditions for future generations to appreciate. Whether it’s a former brewery or bank transforming into a chic hotel or a candy factory evolving into stylish lofts, this Texas city embraces both history and sustainability.
Here’s How to Arrive in Style to the World’s Most Unforgettable Hotels
Make a grand entrance to these equally grand hotels:
Hit the High Notes in Nashville
Nashville’s once-modest skyline continues to evolve as its luxury market grows. Lavish hotel properties are added to the landscape while acclaimed chefs stake claim in the robust culinary scene and premier cultural offerings round out the city’s repertoire.
SponsoredJun 1, 2023
Protected: MORE TO TRAVEL
There’s more to travel than just getting there.
Park Hyatt Tokyo Prepares for Its New Look
London Concours Displays Golden Age Coupes
eFlyer ReviewsMay 31, 2023
Homer and Janet by Homer Review
The Marais District, covering swaths of Paris’ 3rd and 4th arrondissments, has a distinctively gritty glamour that reveals it to be one of the city’s great incubators for new French food, fashion and lifestyle trends. It is here Moïse Sfez took on the challenge of creating street food establishments Homer in 2017 and Janet by Homer in 2022, doing it in such a way they both transcend the novelty of being regional American comfort food offered at stylized lunch counters matching up with New England lobster shacks and New York delis. Overwhelming local response and Sfez winning the 2018 Lobster Roll World’s Championship title in Portland, Maine, solidified him as a Paris restaurateur and one of France’s hottest culinary stars.
Put Yourself First in Arizona
Putting yourself first has never been easier.
eFlyer NewsMay 31, 2023
Air New Zealand to Introduce Skynest Sleeping Pods on Ultra-Long-Haul Flights in 2024
Starting September 2024, Air New Zealand introduces its new Skynest full-length sleeping pods on its ultra-long-haul routes. The new feature will begin on routes between New York and Chicago.